A witness with schizophrenia was the reason a prosecutor allowed a man to plead guilty to manslaughter and get only six years ...

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk ...

New research from the Institute of Psychiatry, Psychology & Neuroscience, supported by the Population Mental Health ...

Panelists discuss how schizophrenia typically evolves through distinct phases—from first-episode psychosis to chronic illness ...

Panelists discuss how relapse is one of the most significant challenges in schizophrenia management, often resulting in ...

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

A review published in Genomic Psychiatry by Dr. Peng Lei and colleagues presents a sweeping synthesis of tau protein research ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...

Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.

When the brain's typical wiring patterns shift from the norm, it leads to psychotic disorders such as schizophrenia and ...